| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/1997 | EP0687263B1 Process for preparing (trans)-6- [2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 07/30/1997 | EP0682521A4 Method of treating damaged mucosal and epithelial tissues with misoprostol. |
| 07/30/1997 | EP0668866B1 Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| 07/30/1997 | EP0609221B1 Antimicrobial dialdehyde composition and methods of use |
| 07/30/1997 | EP0607334B1 Cyclic ureas and analogues useful as retroviral protease inhibitiors |
| 07/30/1997 | EP0547099B1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
| 07/30/1997 | EP0515537B1 Substituted urea compounds and their preparation and use |
| 07/30/1997 | EP0482183B1 Histamine h3-receptor agonist compounds for therapeutic use, pharmaceutical compositions acting as agonists of said receptor and method of preparation |
| 07/30/1997 | CN1155886A Salts of an anti-migraine indole derivative |
| 07/30/1997 | CN1155884A (-)-(3R)-methyl-4-{-4-£4-(4-pyridyl)piperazin-1-YL|phenoxy} butyric acid as cellular adhesion inhibitor |
| 07/30/1997 | CN1155883A Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
| 07/30/1997 | CN1155842A Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 07/30/1997 | CN1155841A Combination therapy for HIV infection |
| 07/30/1997 | CN1155840A Methods of inhibiting endometrial cancer |
| 07/30/1997 | CN1155839A Terpenoidic derivatives (sarcodictyins) useful as antitumor agents |
| 07/30/1997 | CN1155838A Indolinone compounds for the treatment of disease |
| 07/30/1997 | CN1155837A Pharmaceutical compositions containing triclosan or derivatives thereof and EDTA or EGTA |
| 07/30/1997 | CN1155836A Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 07/30/1997 | CN1155835A Oestradiol transdermal therapeutic system comprising hydroscopic additives |
| 07/30/1997 | CN1155546A Aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino£2,3-e|-indol-8-ones and derivatives |
| 07/30/1997 | CN1155545A Substituted benzodihydropyranyl sulfonylurea, its preparation, use in medicines and the medicines containing the same |
| 07/30/1997 | CN1155539A Endothelin receptor antagonists |
| 07/30/1997 | CN1155538A Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 07/30/1997 | CN1155431A Medical spirit for encephalic health and the preparation thereof |
| 07/30/1997 | CN1155418A Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 07/30/1997 | CN1155417A Oral formulations of S(+)-ibuprofen |
| 07/29/1997 | US5652369 Amino acid derivatives |
| 07/29/1997 | US5652368 1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes |
| 07/29/1997 | US5652367 Halo-nitro-isoquinolinone compounds and pharmaceutical compositions thereof |
| 07/29/1997 | US5652365 Process for the production of finasteride |
| 07/29/1997 | US5652361 Macrocyclic ligands and complexes |
| 07/29/1997 | US5652356 Inverted chimeric and hybrid oligonucleotides |
| 07/29/1997 | US5652355 Hybrid oligonucleotide phosphorothioates |
| 07/29/1997 | US5652350 Complementary DNA and toxins |
| 07/29/1997 | US5652274 Therapeutic-wound healing compositions and methods for preparing and using same |
| 07/29/1997 | US5652273 Reduction of hair growth |
| 07/29/1997 | US5652272 Ophthalmic preparations for reducing intraocular pressure |
| 07/29/1997 | US5652271 Therapeutic agents |
| 07/29/1997 | US5652270 Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof |
| 07/29/1997 | US5652269 Substituted hydrazinecarboximidamides and methods of use thereof |
| 07/29/1997 | US5652268 Treating cardiovascular disorders |
| 07/29/1997 | US5652267 Method of using saccharic acid or saccharolactone for treating wrinkles |
| 07/29/1997 | US5652266 Skin improvement, a-hydroxy acid, salicylic acid or ester, and retinoid |
| 07/29/1997 | US5652265 Production of rhein and rhein derivatives |
| 07/29/1997 | US5652264 Cyclohexadiene derivatives useful in the treatment of depression |
| 07/29/1997 | US5652263 Retinoid compositions containing a water soluble antioxidant and a chelator |
| 07/29/1997 | US5652262 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/29/1997 | US5652261 Administering vitamin e mixture; sunscreen, antiinflammatory, antiaging, and wound healing agents |
| 07/29/1997 | US5652260 Adenosine diphosphoribose polymerase binding nitroso aromatic compound useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents |
| 07/29/1997 | US5652259 Administering 3-aroyl-2-arylbenzo(b)thiophene derivatives |
| 07/29/1997 | US5652256 Naftifine hydrochloride gel containing methyl acetate penetration enhancing compound |
| 07/29/1997 | US5652255 Potentiation of bioreductive agents |
| 07/29/1997 | US5652254 Treatment of degenerative diseases, rheumatoid arthritis, psoriasis, cystic fibrosis |
| 07/29/1997 | US5652252 Potassium channel activators |
| 07/29/1997 | US5652251 6-amino-1,4-dihydropyridine compounds as medicaments for treatment of the central nervous system, and processes for their preparation |
| 07/29/1997 | US5652250 N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives and process for their preparation |
| 07/29/1997 | US5652249 Method of treating depression |
| 07/29/1997 | US5652248 Administering eliprodil along with an anticancer agent |
| 07/29/1997 | US5652246 Neurokinin receptor antagonists; nervous system disorders |
| 07/29/1997 | US5652245 Heterocyclic amines having central nervous system activity |
| 07/29/1997 | US5652244 Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652241 Antipsychotic agents, analgesics |
| 07/29/1997 | US5652240 Psychological disorders; anxiolytic agents, antidepressants |
| 07/29/1997 | US5652239 Treatment of strokes, ischemic attack, antagonists of excitatory amino acids glutamate and aspartate |
| 07/29/1997 | US5652238 Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 07/29/1997 | US5652236 Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors |
| 07/29/1997 | US5652235 Method of using spiro piperidines to promote the release of growth hormone |
| 07/29/1997 | US5652234 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent |
| 07/29/1997 | US5652233 Carbapenicillins |
| 07/29/1997 | US5652231 Carcinostatic for hormonotherapy containing dienogest as effective component |
| 07/29/1997 | US5652230 Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy |
| 07/29/1997 | US5652229 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 07/29/1997 | US5652228 Salicylic acid and zwitterionic surfactant, treatment of acne, skin conditioners, removing surface scales |
| 07/29/1997 | US5652227 Inhibition of the degradation of connective tissue matrix protein components in mammals |
| 07/29/1997 | US5652226 Water soluble antibiotics |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652222 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |
| 07/29/1997 | US5652221 Method of treating defective glucose metabolism using synthetic insulin substances |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652124 α-glycosyl hesperidin, and its preparation and uses |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652105 Substrate for detection of mammalian 5-C-DNA methyltransferase |
| 07/29/1997 | US5652095 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/29/1997 | US5652094 Nucleozymes |
| 07/29/1997 | US5651989 Iron/carbon particles for drug delivery, using an external magnetic field to direct drug to target area inside body |
| 07/29/1997 | US5651988 Combination osmotic and bulk forming laxatives |
| 07/29/1997 | US5651987 Ulcer prevention and treatment composition |
| 07/29/1997 | US5651986 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 07/29/1997 | US5651983 Bisacodyl dosage form for colonic delivery |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/29/1997 | US5651974 Imidazolinium betaine amphoteric surfactant |
| 07/29/1997 | US5651973 Therapeutically effective topical application of ST1435 |
| 07/29/1997 | US5651964 Transfection, gene expression, antitumor, anticarcinogenic |
| 07/29/1997 | US5651957 Administering lantibiotic |
| 07/29/1997 | US5651954 Method of using hydrazone containing ligands and metal complexes thereof |
| 07/29/1997 | CA1339147C Salt-type compounds, pharmaceutical compositions containing them and process for preparing same |
| 07/29/1997 | CA1339134C (2s)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b] pyrazin-7-yl) carbamic acid, ethyl ester |
| 07/29/1997 | CA1339132C Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/29/1997 | CA1339128C Compounds |